[Vitamin D deficiency in children admitted to the paediatric intensive care unit]

Raúl Bustos B1, Iván Rodríguez-Nuñez2, Rubén Peña Zavala3

  • 1Unidad de Cuidados Intensivos Pediátricos, Hospital Guillermo Grant Benavente, Concepción, Chile.

Insights

Vitamin D deficiency (VDD) is common in critically ill children, affecting 43.3% of those in the Paediatric Intensive Care Unit (PICU). VDD was linked to increased need for vasopressors, mechanical ventilation, and septic shock.

Area of Science:

  • Pediatric Critical Care Medicine
  • Nutritional Biochemistry
  • Clinical Endocrinology

Background:

  • Vitamin D is crucial for bone health, cardiovascular function, and immune response.
  • Vitamin D deficiency (VDD) is prevalent in critically ill adults, correlating with sepsis and disease severity.
  • Understanding VDD in pediatric intensive care is vital for patient outcomes.

Purpose of the Study:

  • To determine the prevalence of VDD in children admitted to a Paediatric Intensive Care Unit (PICU) in Concepcion, Chile.
  • To investigate the association between VDD and significant clinical outcomes in this pediatric cohort.
  • To provide data for potential therapeutic interventions in critically ill children.

Main Methods:

  • A prospective observational cohort study involving 90 consecutive pediatric patients admitted to the PICU.
  • Serum 25-hydroxyvitamin D (25-OH-D) levels were measured on PICU admission.
  • Severity of illness was assessed using PRISM, PELOD, and vasoactive-inotropic score (VIS); VDD defined as 25-OH-D < 20 ng/ml.

Main Results:

  • The prevalence of VDD among critically ill children was 43.3% (mean 25-OH-D level: 22.8 ng/ml).
  • VDD was significantly associated with increased vasopressor use (RR 1.6), mechanical ventilation (RR 2.2), and septic shock (RR 1.9).
  • A higher likelihood of requiring fluid bolus > 40 ml/kg in the first 24 hours was also observed (RR 1.5).

Conclusions:

  • Vitamin D deficiency is highly prevalent upon admission to the PICU in critically ill children.
  • VDD in this population is associated with adverse clinical outcomes, including severe illness indicators.
  • Further research is warranted to explore the benefits of vitamin D supplementation in pediatric intensive care settings.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
693
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
586
Role of Skin in Vitamin D Synthesis01:23

Role of Skin in Vitamin D Synthesis

The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
8.6K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
360
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.2K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
455